Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 50 citing articles:

mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 415
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 409
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 116
mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 109
Development and Delivery Systems of mRNA Vaccines
Yongjun Liang, Liping Huang, Tiancai Liu
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 104
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine
Xintao Hu, Krithika P. Karthigeyan, Savannah Herbek, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. 455-466
Closed Access | Times Cited: 27
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 16
Where do we Stand after Decades of Studying Human Cytomegalovirus?
Francesca Gugliesi, Alessandra Coscia, Gloria Griffante, et al.
Microorganisms (2020) Vol. 8, Iss. 5, pp. 685-685
Open Access | Times Cited: 73
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O. Saunders, Norbert Pardi, Robert Parks, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 72
mRNA vaccines: Past, present, future
Mia Karam, Georges Daoud
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 4, pp. 491-522
Open Access | Times Cited: 55
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
Sean C. Semple, Robert D. Leone, Christopher Barbosa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 398-398
Open Access | Times Cited: 54
Lipid Nanoparticle-Based Delivery System─A Competing Place for mRNA Vaccines
Xinyu Zhang, Yuanfang Li, Zehua Zhou
ACS Omega (2024) Vol. 9, Iss. 6, pp. 6219-6234
Open Access | Times Cited: 10
A vaccine against cytomegalovirus: how close are we?
Sallie R. Permar, Mark R. Schleiss, S. A. Plotkin
Journal of Clinical Investigation (2025) Vol. 135, Iss. 1
Closed Access | Times Cited: 1
Maternal Microbiome and Infections in Pregnancy
Mohammed Amir, Julia A. Brown, Stephanie L. Rager, et al.
Microorganisms (2020) Vol. 8, Iss. 12, pp. 1996-1996
Open Access | Times Cited: 68
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1345-1345
Open Access | Times Cited: 41
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 6
mRNA Vaccines against Flaviviruses
Clayton J. Wollner, Justin M. Richner
Vaccines (2021) Vol. 9, Iss. 2, pp. 148-148
Open Access | Times Cited: 36
mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents
Sandro Roier, Vidya Mangala Prasad, Monica McNeal, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Safety, Immunogenicity, and Mechanism of a Rotavirus mRNA-LNP Vaccine in Mice
Chenxing Lu, Yan Li, Rong Chen, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 211-211
Open Access | Times Cited: 5
An Update on mRNA-Based Viral Vaccines
Subbiah Jeeva, Ki‐Hye Kim, Chong Hyun Shin, et al.
Vaccines (2021) Vol. 9, Iss. 9, pp. 965-965
Open Access | Times Cited: 30
A promising endeavor against human cytomegalovirus: Predominant epitopes-based recombinant subunit vaccine RH Ec IE1/pp65/pp150
Zonghui Li, Shasha Jiang, Wenxuan Liu, et al.
Virulence (2025)
Open Access
Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases
Seokhwan Chung, Chan Mi Lee, Miqin Zhang
Nanoscale Horizons (2022) Vol. 8, Iss. 1, pp. 10-28
Open Access | Times Cited: 16
Myocarditis: causes, mechanisms, and evolving therapies
Tin Kyaw, Grant R. Drummond, Alex Bobik, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 225-238
Closed Access | Times Cited: 9
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses than that of the Partially Effective gB/MF59 Vaccine
Xintao Hu, Krithika P. Karthigeyan, Savannah Herbek, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top